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ABSTRACT
Acquired hepatocerebral degeneration (AHD) and hepatolenticular degeneration can have 
similar clinical presentations, but when a chronic liver disease and atypical motor findings 
coexist, the distinction between AHD and hepatic encephalopathy (HE) can be even more 
complicated. We describe three cases of AHD (two having HE) with different neuroimaging 
findings, distinct hepatic diseases and similar motor presentations, all presenting chronic 
arterial hypertension and weight loss before the disease manifestations. The diagnosis and 
physiopathology are commented upon and compared with previous reports. In conclusion, 
there are many correlations among HE, hepatolenticular degeneration and AHD, but the 
overlapping of AHD and HE could be more common depending on the clinical knowledge 
and diagnostic criteria adopted for each condition. Since AHD is not considered a priority 
that affects the liver transplant list, the prognosis in AHD patients remains poor, and flow 
interruption in portosystemic shunts must always be taken into account.
Key words: athetosis, chorea, dyskinesias, dystonia, hepatic encephalopathy, 
hepatolenticular degeneration, hyperkinesis, movement disorders.
Degeneração hepatocerebral adquirida e encefalopatia hepática: correlações e 
variedade de apresentações clínicas na doença hepática evidente e subclínica
RESUMO
A degeneração hepatocerebral adquirida (AHD) e a degeneração hepatolenticular 
podem ter apresentações clínicas semelhantes, mas quando uma doença hepática 
crônica e achados motores atípicos coexistem, a distinção entre AHD e encefalopatia 
hepática (HE) pode ser ainda mais complicada. Descrevemos três casos de AHD (dois 
tendo HE) com diferentes achados em neuroimagem, doenças hepáticas distintas e 
apresentações motoras semelhantes, todos com hipertensão arterial e perda de peso 
antes das manifestações motoras. O diagnóstico e a fisiopatologia são comentados e 
comparados com relatos prévios. Concluímos que existem muitas correlações entre HE, 
degeneração hepatolenticular e AHD, mas a sobreposição de HE e AHD pode ser mais 
comum dependendo do conhecimento clínico e da acurácia dos critérios diagnósticos 
adotados para cada enfermidade. Como a AHD não é considerada prioridade na lista 
de transplante hepático, o prognóstico dos pacientes com AHD permanece ruim, e a 
interrupção do fluxo nos shunts portossistêmicos deve ser sempre considerada.
Palavras-chave: atetose, coréia, degeneração hepatolenticular, discinesias, distonia, 
distúrbios do movimento, encefalopatia hepática, hipercinesia.
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The neuroimaging and pathological distinctions 
between chronic acquired hepatocerebral degenera-
tion (AHD) and genetic hepatolenticular degenera-
tion (Wilson’s disease) are well elucidated and applied 
worldwide1-5. In the inherited form there is a metabolic 
dysfunction which leads to copper deposition in basal 
ganglia. Consequently, the disease causes parkinsonism, 
dystonia, and abnormal movements that include athe-
tosis and chorea2,4. In the acquired form, akinetic-rigid 
symptoms were prevalent6,7. Even so, the disease displays 
a wide spectrum of symptoms, and it is not rare that pa-
tients present other signs and symptoms such as cho-
reoathetosis and dystonia8,9. In AHD physiopathology, 
manganese deposition in basal nuclei appears to be a 
key factor10-12.
Hepatic encephalopathy (HE) is a more comprehen-
sive term and is characterized by neuropsychiatric symp-
toms as a complication of a liver disease. The term is 
usually used in the presence of hepatic insufficiency or 
portosystemic shunts, when the central nervous system 
shows no signs of disease in current neuroimaging 
exams. Nevertheless, encephalic abnormalities may al-
ready have been found, including primary astrocytop-
athy with type 2 Alzheimer cells in a wide range of brain 
structures in patients who died from HE13,14. The same 
cells are also encountered in the brain of patients diag-
nosed with AHD15,16, showing a common neurological 
finding in these two situations.
Thus, the question of whether of HE is completely re-
versible is controversial, and some neurological deficits 
may persist17,18. However, until now there is no consensus 
about whether repeated HE episodes constitute a key 
factor in AHD development. Some reports did not find 
any relationship between HE and AHD6,8. However, other 
studies showed a direct relationship between the number 
of episodes and the probability of AHD occurrence19,20, 
and some authors prefer the diagnosis of chronic he-
patic encephalopathy for patients with a chronic liver 
disease and long-term neurological signs and symptoms 
and without apparent signs of manganese deposition in 
the brain21.
In this paper we describe three AHD cases in which 
chorea was the prominent sign. All three manifested se-
vere weight loss prior to chorea, and two had persistent 
HE. Correlations between clinical findings, neuroim-
aging studies and liver disease severity were discussed. 
The prognosis and treatment options are briefly de-
scribed and analyzed.
METHOD
Written informed consent to participate in the study 
was obtained according to the Declaration of Helsinki. 
Obtained neuroimages and all other determinations were 
part of routine examination of patients with neurolog-
ical symptoms associated with suspected hepatic disease.
Case 1
A 49-year-old man came to the hospital in June 2004 
with cirrhosis and chronic arterial hypertension, and 
reported his consumption of at least 200 ml of brandy 
(64 g of alcohol) per day for 26 years. He had tense as-
cites, pronounced edema of both legs and inconstant 
flapping tremor. Clinical and laboratory tests were com-
patible with the cirrhosis Child-Pugh score of 12 (Class 
C). He underwent three additional episodes of overt HE 
in 2005, when abdominal ultrasonography showed cir-
rhotic liver, splenomegaly, recanalization of the umbilical 
vein and collateral veins in the abdomen. Until this time 
he had shown clear recovery from hepatic encephalop-
athy and ceased taking lactulose and diuretics, but con-
tinued to present chronic somnolence, an attention def-
icit, impaired concentration, and postural hand tremor. 
He stopped consuming alcohol and reported substantial 
weight loss within the year (10 Kg).
He was readmitted in July 2006 due to abruptly im-
paired cognitive function associated with involuntary 
movements. His liver cirrhosis received a Child-Pugh 
score of 9 (Class B) but he did not present ascites. He 
had mild consciousness impairment associated with 
symmetrical ballistic and choreoathetoid movements, 
prominent orobuccolingual (OBL) dyskinesia and dys-
arthric speech. Urinary copper and serum ceruloplasmin 
were normal and slit lamp examination did not show 
Kayser-Fleischer rings. Cranial Magnetic Resonance Im-
aging (MRI) showed T1 weighted symmetrical hyperin-
tense globus pallidus and putamen (Fig 1). Haloperidol 
2 mg/day and lactulose 20 ml q.i.d. produced a good ini-
tial recovery, but did not avoid symptom recurrences. 
Hepatic transplantation was indicated but his model for 
end-stage liver disease (MELD) score was still very low. 
Tremors and dysarthria remained and orobuccolingual 
dyskinesia became progressively unmanageable. At that 
time he had clear difficulty swallowing. Since the patient 
had manifested previous esophageal variceal bleeding, 
collateral vein embolization was contraindicated.
The patient’s motor disturbances were seen only 
during the progressively rarer moments he was awake. 
He developed pneumonia, renal insufficiency and pres-
sure ulcers and died after a septic shock episode in De-
cember 2007.
Case 2
The second patient is a 56-year-old man who con-
sumes on average 2 liters of brandy (about 320 g of al-
cohol) daily and tells of alcohol abuse since the age of 
eight. In March 2009 he underwent neurological treat-
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ment for a 4-year history of chorea that initially affected 
the left hand and more recently the arms, face and trunk, 
causing a walking disability. He had chronic osteomy-
elitis and during the treatment suffered a chronic weight 
loss during the last years (6 Kg). He exhibited vascular 
spiders, a palpable spleen and an increased liver consis-
tency that led to a diagnostic hypothesis of portal hy-
pertension and cirrhosis. He showed bilateral choreo-
athetosis including abnormal movements in the face. 
Endoscopy was used to look for other manifestations of 
portal hypertension, and portal hypertensive gastrop-
athy was encountered. Abdominal ultrasonography did 
not reveal portosystemic shunts. Liver biopsy showed 
no signs of cirrhosis. Cranial MRI was performed using 
standard axial, sagittal, and coronal spin-echo. T1 and 
T2 sequence images showed no signs of metal deposits, 
but did reveal abnormalities in the mesencephalic tegu-
mentum with hypersignal on T2-weighted images (Fig 2). 
The patient improved after the introduction of haloper-
idol 2 mg/day and cessation of alcohol consumption.
Case 3
The third patient is a 63-year-old woman who had ar-
terial hypertension, obesity, and diabetes, but never con-
sumed alcohol. She was hospitalized in August 2009 be-
cause of a severe HE episode. According to her daughter, 
she had weakness in both legs five years ago, and invol-
untary movements of the tongue, neck, arms, and legs 
in the last eighteen months. After many falling episodes 
in this period, she has not been able to walk since Feb-
ruary 2009. In the same year she began to have gagging 
episodes associated with feeding, without complaints of 
dysphagia, and had marked weight loss, which was not 
quantified because of her difficulty in standing.
Abdominal ultrasonography showed many dilated 
and tortuous vessels around the left gastric vein, signs of 
chronic hepatic disease and splenomegaly, but no ascites. 
Slit lamp examination did not show Kayser-Fleischer 
rings. Liver biopsy confirmed the diagnosis of cirrhosis 
and autoimmune hepatitis. Clinical and laboratory 
data revealed a Child-Pugh score of 8 (Class B). Serum 
Fig 2. [A-D] MRI from patient 2, acquired with 3.0 Tesla equipment. The arrows indicate the normal T1-weighted signal of the 
globus pallidus [A-B] and the hyperintense signal in the mesencephalic tegmentum [C-D] on T2-weighted images, respec-
tively TSE and FLAIR.
Fig 1. [A-D] Magnetic resonance images from patient 1, acquired with 1.5 Tesla equipment. The arrows point to the hyperin-
tensity of the globus pallidus in both T1- [A-C], and T2-weighted sequences [D]. The T1 shortening is supposed to be related 
to deposition of paramagnetic substances and the T2 lengthening to astrogliosis.
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and urinary copper were normal, but serum ammonia 
was very high (193 µmol/ml). MRI showed no signs of 
metal deposits or any other specific abnormalities. The 
patient improved with haloperidol 1 mg/day and lactu-
lose 20 ml q.i.d, but symptoms later reappeared despite 
the medications.
DISCUSSION
In 1965, Victor et al.20 described the clinical and path-
ological aspects of acquired hepatocerebral degenera-
tion (AHD) and proposed its universally adopted name. 
Like other previous works, the study did not find any 
changes in copper metabolism and linked the symptoms 
to the blood ammonia levels. Today there appears to be 
no question that manganese accumulation, among other 
less evident disturbances, plays a central role in the phys-
iopathology of AHD10-12,19.
Analysis of 1.5 T and 3.0 T nuclear magnetic reso-
nance images (MRI) of our patients showed three dis-
tinct patterns. In patient 1, T1-weighted images showed 
increased signal in the globus pallidus and putamen, 
and T2 images reveal increased signal in the globus pal-
lidus. This finding is considered a marker for AHD with 
manganese deposition in basal nuclei10. The hyperinten-
sity in basal ganglia T1 images is evidence of paramag-
netic substance deposit associated with astrocyte or-
ganelle proliferation22, associated with lengthening in 
T2 depending on the increase of fluid linked to gliosis. 
Complementary studies have shown that despite ele-
vated copper in different areas of the brain, it is man-
ganese that is deposited in the globus pallidus and pu-
tamen at levels up to seven times higher than controls 
in hepatic-insufficiency patients without neurological 
signs23, and the same finding was observed in those pre-
senting neurological risk10. Other authors showed that al-
though symmetric hyperintense globus pallidus in a T1- 
weighted cranial MRI in patients with cirrhosis precedes 
hepatocerebral disease, there is no correlation with clin-
ical symptoms19, and that shortening the T1 relaxation 
time in MRI (caused by the paramagnetic properties of 
deposited substances) does not reflect the amount of ac-
cumulated cerebral manganese24.
The second case did not show the characteristic ra-
diological T1 hyperintensity that suggests manganese de-
position, but clinical manifestations were very similar 
to cases 1 and 3. Although MRI images showed no ab-
normalities in the globus pallidus neuroimaging, there 
were no other reasons for the involuntary movements 
and the patient had clear signs of portal hypertension. 
There were reports of AHD without MRI signs of man-
ganese deposition in patients with chronic hepatic dis-
ease, moderate portal fibrosis, and canalicular prolifer-
ation25,26. Similarly to our case in which MRI shows T1 
hypointensity and T2 hyperintensity signal in mesen-
cephalus but also in subcortical and deep white matter, 
these authors found symmetrical hypointense T1 and 
hyperintense T2 images in cerebelar peduncle, subcor-
tical and deep white matter25. The pathological correla-
tions in these previous reports demonstrate the pres-
ence of microscopic spongy degeneration with numerous 
Alzheimer type II astrocytes in basal ganglia. The same 
findings were seen in patients suffering from cirrhosis 
with MRI exams showing hyperintense globus pallidus 
in T1 MRI21. Of interest, our non-cirrhotic patient has 
an apparently normal globus pallidus in MRI. Another 
finding of Saporta et al.25 that was highlighted in our pa-
tients is marked weight loss, which could be the source of 
toxins release from adipose tissue. Similarly, our patients 
still had chronic arterial hypertension, but this disease 
has no clear correlation with the AHD physiopathology. 
These findings should be described in future reports on 
AHD to allow a more detailed discussion about the dis-
ease’s pathogenesis.
Our two cirrhotic patients had marked portal hyper-
tension and clear portosystemic shunts in Doppler ul-
trasound exam, while the non-cirrhotic patient had only 
signs of portal hypertension and no evidence of cirrhosis 
in an adequate liver biopsy. According to this finding and 
the previous studies, we infer that neural lesions caused 
by AHD and HE have an almost independent course, and 
the absence of cirrhosis could explain the lack of HE in 
the presentation of our second patient. If he returns to al-
cohol consumption and/or develops liver cirrhosis, prob-
ably some signs of HE would appear. Additionally, if every 
patient with HE could be monitored by high-quality MRI 
exams, any neurological effect of a hypothetical trigger 
such as weight loss, arterial hypertension or new por-
tosystemic shunts could be adequately documented.
Both HE and AHD share a common etiopathogenic 
finding, namely the presence of portosystemic shunts27, 
but in our second patient we still did not find any signal 
of portal shunting, even in the presence of portal hyper-
tension. Given that the portosystemic shunts appear to 
be the first step in the development of type II Alzheim-
er’s cells in both HE and AHD13-15,27, we could hypothe-
size that this patient had pathologic shunts still not vi-
sualized by the Doppler exam at that time. 
The third patient shows the classical clinical picture 
of AHD, with portosystemic shunts and cirrhosis. Her 
MRI exams did not show T1 hyperintensity, but revealed 
some findings compatible with spongy degeneration as-
sociated with hyperintensity in T2 and Flair. As in the 
first patient, her clinical presentation was punctuated by 
severe episodes of HE, which underwent incomplete re-
mission after ammonia reduction treatment.
Previous studies registered the predominance of hy-
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pokinetic forms with bradykinesia and rigidity in AHD6,7. 
Even so, there are many other reports in which chorea 
emerged as the prominent manifestation. Choreoathe-
tosis is almost invariably present in the face, affecting the 
tongue, eyes and lips, with the appearance of so called 
grimacing3,16,20. Nonetheless, even patients with different 
clinical presentations have an invariable association with 
direct or indirect signs of portocaval shunts9,11,28,29.
The spectrum of symptoms can be similar in some 
patients when AHD and HE coexist, but the pathogen-
esis of both conditions are complex and not fully under-
stood6,7,8,15,30. Given that the AHD physiopathology is not 
only associated with manganese deposition31, comple-
mentary studies are needed to identify other metabolic 
abnormalities which could elucidate the causes of clin-
ical and neuroimaging variations. According to the pre-
vious studies and a detailed analysis of our patients, we 
recognize a multifactorial physiopathology with a wide 
range of clinical presentations not always correlated with 
HE but certainly associated with portal hypertension and 
different degrees of portosystemic shunts, not always ob-
served in Doppler ultrasonography.
Clinical diagnosis in patients with chronic hepato-
cerebral degeneration is often difficult to achieve due to 
the simultaneous symptoms related to HE and findings 
linked to the chronic form, with more extensive cerebral 
lesions. The three cases presented herein have extrapyra-
midal symptoms affecting the face and tongue and were 
well-controlled initially by means of neuroleptics. We 
seek to emphasize the multiple pathogenic factors asso-
ciated with hepatic impairment and the different imaging 
findings obtained during the etiological investigation. 
Both cirrhotic patients presented in the current re-
port had lower MELD scores and visible portosystemic 
shunts in Doppler exams. This morbid association is a 
paradox in the prognostic factors associated with cir-
rhosis, in which a serious complication of hepatic dis-
ease has no priority in the liver transplant list because 
AHD is not considered a special situation. A recent re-
port showed a patient with Parkinsonism and dementia 
associated with MRI hypersignal in T1, which was inter-
preted as evidence of encephalic manganese deposition. 
The authors considered this finding as the determinant 
factor for indicating a liver transplant32. The indication 
in this setting is reasonable, since about 20% of patients 
selected for liver transplant have extrapyramidal signs.
Despite the severity of any neurological impairment 
caused by liver diseases, a difficult task in these patients 
is to distinguish HE from other forms of hepatocerebral 
disease when neuroimaging findings are not typical of 
AHD or hepatolenticular degeneration. In a recent re-
view, Ferrara and Jankovic3 assumed that movement 
and cognitive disorders have distinct causes in cirrhosis. 
Thus, in AHD there is no consciousness impairment and 
poor response to ammonia reduction, in contrast to what 
occurs in HE. Therefore, in addition to a careful radio-
logical exam, repeated evaluations of the consciousness 
level are still necessary to make this differentiation. How-
ever, the overlapping of AHD and HE is possible, and 
despite the fact that each condition requires custom-
ized management, interrupting the flow in the portosys-
temic shunts must always be considered when a short-
term liver transplant is not feasible. With this strategy 
we probably could reduce the neurological deficits seen 
in the post-transplant patien
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